glp 1 agonist guidelines Glucagon-Like Peptide-1 Receptor Agonists in Perioperative Care Updated guidance from the PCDS

Had missed this detail @Humana was selected by CMS as the central processor for the Medicare GLP-1 Bridge Makes sense given Humana already administers prescription drug access for the LI NET program

While our current treatments have shown significant therapeutic benefits, there still appear to be some patients who, despite aggressive therapy, good adherence, and inhaler technique, continue to have exacerbations

This review highlights key clinical considerations across reproductive stages, emphasizes the primacy of human exposure data where available, and identifies critical evidence gaps requiring future prospective study.

It can lead to weight loss, better glycemic control, and reduced cardiometabolic risk factors

Disclaimer: This article is for informational purposes only and is not medical advice

Stratified analyses showed no differences between subgroups